Close Menu

This article has been updated from a previous version to clarify that Helix has initiated COVID-19 testing while FDA Emergency Use Authorization is pending.

NEW YORK – Helix said on Monday afternoon that it is partnering with California's San Diego County to provide up to 2,000 COVID-19 molecular diagnostics tests per day out of its San Diego lab.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.